Company: OCEA
Filing Date: 2025-04-08
Form Type: 10-K
Source: 0001641172-25-003155
Chunk: 2278

Company: Ocean Biomedical, Inc.
Filing Date: 2025-04-08
Form: 10-K
Item: Item 1A
Chunk 2278
---
ution to our
stockholders.

We
qualify as an “emerging growth company” as well as a “smaller reporting company” within the meaning of the Securities
Act, and if we take advantage of certain exemptions from disclosure requirements available to emerging growth companies, this could make
our securities less attractive to investors and may make it more difficult to compare our performance with other public companies.

130

We
qualify as an “emerging growth company” within the meaning of the Section 2(a)(19) of the Securities Act, as modified by
the JOBS Act. As such, we may take advantage of certain exemptions from various reporting requirements that are applicable to other public
companies that are not emerging growth companies for as long as we continue to be an emerging growth company, including, but not limited
to, (i) not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, (ii) reduced
disclosure obligations regarding executive compensation in our periodic reports and proxy statements and (iii) exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously
approved. As a result, our stockholders may not have access to certain information they may deem important. We will remain an emerging
growth company until the earliest of (i) the last day of the fiscal year in which the market value of our common stock that is held by
non-affiliates exceeds $700.0 million as of the end of that year’s second fiscal quarter, (ii) the last day of the fiscal year
in which we have total annual gross revenue of $1.1 million or more during such fiscal year (as indexed for inflation), (iii) the date
on which we have issued more than $1.0 million in non-convertible debt in the prior three-year period or (iv) the last day of the fiscal
year following the fifth anniversary of the date of the first sale of our common stock, as defined by the JOBS Act. Investors may find
our securities less attractive because we will rely on these exemptions. If some investors find our securities less attractive as a result
of its reliance on these exemptions, the trading prices of our securities may be lower than they otherwise would be, there may be a less
active trading market for its securities and the trading prices of its securities may be more volatile.

Further,
Section 102(b)(1) of